vs
Side-by-side financial comparison of Clearfield, Inc. (CLFD) and HARVARD BIOSCIENCE INC (HBIO). Click either name above to swap in a different company.
Clearfield, Inc. is the larger business by last-quarter revenue ($34.3M vs $23.7M, roughly 1.4× HARVARD BIOSCIENCE INC). Clearfield, Inc. runs the higher net margin — -1.8% vs -12.0%, a 10.2% gap on every dollar of revenue. On growth, Clearfield, Inc. posted the faster year-over-year revenue change (-3.2% vs -3.3%). HARVARD BIOSCIENCE INC produced more free cash flow last quarter ($-545.0K vs $-2.4M). Over the past eight quarters, HARVARD BIOSCIENCE INC's revenue compounded faster (-1.6% CAGR vs -3.5%).
Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.
Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. It is traded on NASDAQ under the stock symbol HBIO.
CLFD vs HBIO — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $34.3M | $23.7M |
| Net Profit | $-614.0K | $-2.8M |
| Gross Margin | 33.2% | 59.7% |
| Operating Margin | -5.3% | 7.2% |
| Net Margin | -1.8% | -12.0% |
| Revenue YoY | -3.2% | -3.3% |
| Net Profit YoY | 67.8% | -15916.7% |
| EPS (diluted) | $-0.04 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.3M | $23.7M | ||
| Q3 25 | $23.4M | $20.6M | ||
| Q2 25 | $49.9M | $20.4M | ||
| Q1 25 | $47.2M | $21.8M | ||
| Q4 24 | $29.7M | $24.6M | ||
| Q3 24 | $5.6M | $22.0M | ||
| Q2 24 | $48.8M | $23.1M | ||
| Q1 24 | $36.9M | $24.5M |
| Q4 25 | $-614.0K | $-2.8M | ||
| Q3 25 | $-9.1M | $-1.2M | ||
| Q2 25 | $1.6M | $-2.3M | ||
| Q1 25 | $1.3M | $-50.3M | ||
| Q4 24 | $-1.9M | $18.0K | ||
| Q3 24 | — | $-4.8M | ||
| Q2 24 | $-447.0K | $-2.9M | ||
| Q1 24 | $-5.9M | $-4.7M |
| Q4 25 | 33.2% | 59.7% | ||
| Q3 25 | 53.2% | 58.4% | ||
| Q2 25 | 30.5% | 56.4% | ||
| Q1 25 | 30.1% | 56.0% | ||
| Q4 24 | 29.2% | 57.1% | ||
| Q3 24 | — | 58.1% | ||
| Q2 24 | 21.9% | 57.2% | ||
| Q1 24 | 7.7% | 60.3% |
| Q4 25 | -5.3% | 7.2% | ||
| Q3 25 | 10.3% | 1.0% | ||
| Q2 25 | 3.0% | -4.0% | ||
| Q1 25 | 0.6% | -228.1% | ||
| Q4 24 | -6.9% | 0.0% | ||
| Q3 24 | — | -8.5% | ||
| Q2 24 | -4.7% | -9.0% | ||
| Q1 24 | -26.4% | -9.3% |
| Q4 25 | -1.8% | -12.0% | ||
| Q3 25 | -38.8% | -6.0% | ||
| Q2 25 | 3.2% | -11.2% | ||
| Q1 25 | 2.8% | -231.2% | ||
| Q4 24 | -6.4% | 0.1% | ||
| Q3 24 | — | -21.9% | ||
| Q2 24 | -0.9% | -12.7% | ||
| Q1 24 | -16.0% | -19.1% |
| Q4 25 | $-0.04 | $-0.06 | ||
| Q3 25 | $-0.65 | $-0.03 | ||
| Q2 25 | $0.11 | $-0.05 | ||
| Q1 25 | $0.09 | $-1.14 | ||
| Q4 24 | $-0.13 | $0.01 | ||
| Q3 24 | — | $-0.11 | ||
| Q2 24 | $-0.04 | $-0.07 | ||
| Q1 24 | $-0.40 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $96.4M | $8.6M |
| Total DebtLower is stronger | — | $35.9M |
| Stockholders' EquityBook value | $249.7M | $13.7M |
| Total Assets | $268.1M | $80.1M |
| Debt / EquityLower = less leverage | — | 2.61× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $96.4M | $8.6M | ||
| Q3 25 | $106.0M | $6.8M | ||
| Q2 25 | $117.2M | $7.4M | ||
| Q1 25 | $112.0M | $5.5M | ||
| Q4 24 | $113.0M | $4.1M | ||
| Q3 24 | $129.0M | $4.6M | ||
| Q2 24 | $123.8M | $4.0M | ||
| Q1 24 | $142.9M | $4.3M |
| Q4 25 | — | $35.9M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $34.9M | ||
| Q1 25 | — | $36.4M | ||
| Q4 24 | — | $37.0M | ||
| Q3 24 | $2.2M | $34.9M | ||
| Q2 24 | $2.1M | $35.7M | ||
| Q1 24 | — | $35.6M |
| Q4 25 | $249.7M | $13.7M | ||
| Q3 25 | $256.2M | $14.1M | ||
| Q2 25 | $264.5M | $15.7M | ||
| Q1 25 | $265.9M | $14.8M | ||
| Q4 24 | $267.4M | $63.3M | ||
| Q3 24 | $275.8M | $65.3M | ||
| Q2 24 | $274.6M | $67.2M | ||
| Q1 24 | $279.2M | $68.8M |
| Q4 25 | $268.1M | $80.1M | ||
| Q3 25 | $306.2M | $78.0M | ||
| Q2 25 | $314.7M | $80.1M | ||
| Q1 25 | $310.9M | $79.8M | ||
| Q4 24 | $303.2M | $126.6M | ||
| Q3 24 | $315.3M | $131.2M | ||
| Q2 24 | $318.1M | $128.9M | ||
| Q1 24 | $315.4M | $133.2M |
| Q4 25 | — | 2.61× | ||
| Q3 25 | — | 2.41× | ||
| Q2 25 | — | 2.22× | ||
| Q1 25 | — | 2.45× | ||
| Q4 24 | — | 0.58× | ||
| Q3 24 | 0.01× | 0.53× | ||
| Q2 24 | 0.01× | 0.53× | ||
| Q1 24 | — | 0.52× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.4M | $-96.0K |
| Free Cash FlowOCF − Capex | $-2.4M | $-545.0K |
| FCF MarginFCF / Revenue | -7.1% | -2.3% |
| Capex IntensityCapex / Revenue | 2.9% | 1.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $5.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.4M | $-96.0K | ||
| Q3 25 | — | $1.1M | ||
| Q2 25 | $7.9M | $2.8M | ||
| Q1 25 | $3.0M | $3.0M | ||
| Q4 24 | $7.2M | $1.7M | ||
| Q3 24 | $22.2M | $-842.0K | ||
| Q2 24 | $4.0M | $-846.0K | ||
| Q1 24 | $-5.7M | $1.4M |
| Q4 25 | $-2.4M | $-545.0K | ||
| Q3 25 | — | $877.0K | ||
| Q2 25 | $7.5M | $2.7M | ||
| Q1 25 | $654.0K | $2.5M | ||
| Q4 24 | $5.1M | $1.4M | ||
| Q3 24 | $18.2M | $-1.7M | ||
| Q2 24 | $2.8M | $-1.7M | ||
| Q1 24 | $-7.7M | $758.0K |
| Q4 25 | -7.1% | -2.3% | ||
| Q3 25 | — | 4.3% | ||
| Q2 25 | 15.1% | 13.0% | ||
| Q1 25 | 1.4% | 11.4% | ||
| Q4 24 | 17.1% | 5.8% | ||
| Q3 24 | 323.0% | -7.8% | ||
| Q2 24 | 5.8% | -7.2% | ||
| Q1 24 | -20.8% | 3.1% |
| Q4 25 | 2.9% | 1.9% | ||
| Q3 25 | 2.0% | 1.0% | ||
| Q2 25 | 0.8% | 0.4% | ||
| Q1 25 | 5.1% | 2.4% | ||
| Q4 24 | 7.0% | 1.2% | ||
| Q3 24 | 71.4% | 4.0% | ||
| Q2 24 | 2.5% | 3.5% | ||
| Q1 24 | 5.3% | 2.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.93× | — | ||
| Q1 25 | 2.30× | — | ||
| Q4 24 | — | 95.83× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLFD
Segment breakdown not available.
HBIO
| Instruments Equipment Software And Accessories | $21.6M | 91% |
| Service Maintenance And Warranty Contracts | $2.1M | 9% |
